Literature DB >> 18186038

Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries.

Tom Stargardt1.   

Abstract

This paper assesses variations in the cost of primary hip replacement between and within nine member states of the European Union (EU). It also compares the cost of service with public-payer reimbursements. To do so, data on cost and reimbursement were surveyed at the micro-level in 42 hospitals in Denmark, England, France, Germany, Hungary, Italy, The Netherlands, Poland, and Spain. The total cost of treatment ranged from 1290 euros (Hungary) to 8739 euros (The Netherlands), with a mean cost of 5043 euros (STD +/- 2071 euros). The main cost drivers were found to be implants (34% of total cost on average) and ward costs (20.9% of total cost on average). A one-way random effects analysis of variance model indicated that 74.0% of variation was between and only 26% of variation was within countries. In a two-level random-intercept regression model, purchasing-power parities explained 79.4% of the explainable between-country variation, while the percentage of uncemented implants used and the number of beds explained 12.1 and 1.6% of explainable within-country variation, respectively. The large differences in cost and reimbursement between Poland, Hungary, and the other EU member states shows that primary total hip replacement is a highly relevant case for cross-border care. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18186038     DOI: 10.1002/hec.1328

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  21 in total

1.  Privatization of local public hospitals: effect on budget, medical service quality, and social welfare.

Authors:  Hiroshi Aiura; Yasuo Sanjo
Journal:  Int J Health Care Finance Econ       Date:  2010-06-16

Review 2.  [Classification of prosthetic loosening and determination of wear particles].

Authors:  M Otto
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

3.  What Are the Uses and Limitations of Time-driven Activity-based Costing in Total Joint Replacement?

Authors:  Shravani Pathak; Daniel Snyder; Thomas Kroshus; Aakash Keswani; Prakash Jayakumar; Kelly Esposito; Karl Koenig; David Jevsevar; Kevin Bozic; Calin Moucha
Journal:  Clin Orthop Relat Res       Date:  2019-09       Impact factor: 4.176

4.  Comparison of pre- and post-operative health-related quality of life and length of stay after primary total hip replacement in matched English and German patient cohorts.

Authors:  Matthias Vogl; Reiner Leidl; Werner Plötz; Nils Gutacker
Journal:  Qual Life Res       Date:  2014-08-15       Impact factor: 4.147

5.  Cost of external fixation vs external fixation then nailing in bone infection.

Authors:  Khaled Mohamed Emara; Ramy Ahmed Diab; Khaled Abd El Ghafar
Journal:  World J Orthop       Date:  2015-01-18

6.  [Pre- and postoperative fast-track treatment concepts in spinal surgery : patient information and patient cooperation].

Authors:  C Fleege; M Arabmotlagh; A Almajali; M Rauschmann
Journal:  Orthopade       Date:  2014-12       Impact factor: 1.087

7.  [Economic impact of infected total hip arthroplasty in the German diagnosis-related groups system].

Authors:  M Haenle; C Skripitz; W Mittelmeier; R Skripitz
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

8.  Obesity increases length of stay and direct medical costs in total hip arthroplasty.

Authors:  Hilal Maradit Kremers; Sue L Visscher; Walter K Kremers; James M Naessens; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2013-10-08       Impact factor: 4.176

9.  Hospital costs of total hip arthroplasty for developmental dysplasia of the hip.

Authors:  Ali Ashraf; A Noelle Larson; Hilal Maradit-Kremers; Walter K Kremers; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2014-04-11       Impact factor: 4.176

10.  Determinants of direct medical costs in primary and revision total knee arthroplasty.

Authors:  Hilal Maradit Kremers; Sue L Visscher; James P Moriarty; Megan S Reinalda; Walter K Kremers; James M Naessens; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.